# Pfizer-Tweets-Analysis-and-Visualisations
## To explore the tweets about the new Pfizer & BioNTech vaccine to understand the public reception, the topics discussed, the positive and negative sentiments related to the vaccine.

**Author** : SHAILESH DHAMA

Study the subjects of recent tweets about the vaccine made in collaboration by Pfizer and BioNTech, perform various NLP tasks on this data source.
                
### Dataset :

The dataset consists of a csv file: vaccination_tweets.csv

## Approach:

### Data processing & Exploratory Data Analysis:

    1.Import Libraries
    2.Load Data
    3.Exploratory Data Analysis[EDA]
    4.Followers and Retweets
    5.Missing Values
    6.Unique Values
    7.Most frequent values
    8.Distribution of words in text column
    9.Data distribution
    10.Word-Clouds
    11.Hashtags
    12.Correlation
           
## RESULTS :

#### Top-10 country most affected by COVID-19
![Top-10 country most affected by COVID-19](./COVID_1.png)

#### Top-10 country most killed by COVID-19
![Top-10 country most killed by COVID-19](./COVID_2.png)

#### COVID-19 confirmed case distribution
![COVID-19 confirmed case distribution](./COVID_3.png)
![COVID-19 confirmed case distribution](./COVID_4.png)

#### 6 countries having huge COVID-19 confirmed cases in the world
![6 countries having huge COVID-19 confirmed cases in the world](./COVID_5.png)

#### 6 countries having huge COVID-19 deaths in the world
![6 countries having huge COVID-19 deaths in the world](./COVID_6.png)

#### SARS-COV2 cases in the worldwide
![SARS-COV2 cases](./COVID_7.png)

#### SARS-COV2 fatalities in the worldwide
![SARS-COV2 fatalities in the worldwide](./COVID_8.png)

#### COVID-19 most affected cases in the 20 countries
![COVID-19 most affected](./COVID_9.png)

#### SARS-COV2 incidence per 100000 inhabitants
![SARS-COV2 incidence per 100000 inhabitants](./COVID_14.png)

#### SARS-COV2 new cases worldwide
![SARS-COV2 new cases worldwide](./COVID_16.png)

#### SARS-COV2 new fatalities worldwide
![SARS-COV2 new fatalities worldwide](./COVID_18.png)

#### SARS-COV2 lethality worldwide
![SARS-COV2 lethality worldwide](./COVID_20.png)

#### Population and population density
![Population and population density](./COVID_22.png)

#### Cases and deaths per state
![Cases and deaths per state](./COVID_23.png)

#### Cases normalised to population
![Number of Seasons in Web-Series](./COVID_24.png)

#### Deaths normalised to population
![Web-Series with 1 Season](./COVID_25.png)

#### Cases in counties over their mean
![Cases in counties over their mean](./COVID_26.png)

#### Hot-Spots in Germany
![Hot-Spots in Germany](./COVID_27.png)

#### Time dependence
![Time dependence](./COVID_28.png)
![Time dependence](./COVID_29.png)

#### Age and Gender dependence
![Age and Gender dependence](./COVID_30.png)

#### Development of Confirmed Cases in Germany
![Development of Confirmed Cases in Germany](./COVID_31.png)

#### Incremental Development of Confirmed Cases in Germany
![Incremental Development of Confirmed Cases in Germany](./COVID_32.png)

#### Relative Changes of Confirmed Cases in Germany
![Relative Changes of Confirmed Cases in Germany](./COVID_35.png)

#### COVID-19 Impacts during weekdays
![COVID-19 Impacts during weekdays](./COVID_38.png)

#### COVID-19 Logarithmic Impacts during weekdays
![COVID-19 Logarithmic Impacts during weekdays](./COVID_39.png)
![COVID-19 Logarithmic Impacts during weekdays](./COVID_40.png)

#### Incremental Deaths vs Incremental Cases in Germany
![Incremental Deaths vs Incremental Cases in Germany](./COVID_51.png)

### COMPARISON BETWEEN GERMANY AND INDIA IN COVID-19 SPREAD
![COMPARISON BETWEEN GERMANY AND INDIA IN COVID-19 SPREAD](./COVID_52.png)
![COMPARISON BETWEEN GERMANY AND INDIA IN COVID-19 SPREAD](./COVID_53.png)
![COMPARISON BETWEEN GERMANY AND INDIA IN COVID-19 SPREAD](./COVID_54.png)
![COMPARISON BETWEEN GERMANY AND INDIA IN COVID-19 SPREAD](./COVID_55.png)
![COMPARISON BETWEEN GERMANY AND INDIA IN COVID-19 SPREAD](./COVID_56.png)
![COMPARISON BETWEEN GERMANY AND INDIA IN COVID-19 SPREAD](./COVID_57.png)
![COMPARISON BETWEEN GERMANY AND INDIA IN COVID-19 SPREAD](./COVID_58.png)
![COMPARISON BETWEEN GERMANY AND INDIA IN COVID-19 SPREAD](./COVID_59.png)

### Correlations
#### Pearson correlation
![Pearson correlation](./COVID_60.png)

#### Spearman correlation
![Spearman correlation](./COVID_61.png)

### For further information:

Please review the narrative of our analysis in [our jupyter notebook](./covid19-eda-comparison-between-india-germany.ipynb)

For any additional questions, please contact **shaileshettyd@gmail.com)

##### Repository Structure:

```
├── README.md                                                                                                                            <- The top-level README for reviewers
├── covid-19-analysis-and-visualisations.html;covid19-eda-comparison-between-india-germany.ipynb;geospatial-demographics-analysis.ipynb  <- narrative documentation of analysis
├── netflix_titles.csv                                                                                                                   <- Dataset
└── images                                                                                                                               <- generated from code
```
## Citing :

```
@misc{Shailesh:2020,
  Author = {Shailesh Dhama},
  Title = {COVID-19 Trends in Deutschland},
  Year = {2020},
  Publisher = {GitHub},
  Journal = {GitHub repository},
  Howpublished = {\url{https://github.com/ShaileshDhama/COVID-19-Trends-in-Deutschland}}
}
```
